| OPSONA THERAPEUTICS, LTD. Patent applications |
| Patent application number | Title | Published |
|---|
| 20110293601 | COMPOSITION AND METHOD FOR TREATMENT OF REPERFUSION INJURY AND TISSUE DAMAGE - The present invention provides compounds and methods for the treatment and prophylaxis of ischemia reperfusion injury. In particular the invention provides compounds which function to suppress Toll-like Receptor 2 biological function or expression. | 12-01-2011 |
| 20100297147 | COMPOSITIONS AND METHODS FOR MODULATING TLR14 ACTIVITY - Methods and compositions for modulating neural cell function using antagonists of TLR14 are disclosed. In particular, methods for treating, preventing and/or diagnosing TLR14-associated neurodegenerative conditions and/or disorders are disclosed. Screening methods for evaluating TLR14 modulators, e.g., agonists and antagonists, are also disclosed. | 11-25-2010 |
| 20100278817 | COMPOUNDS AND METHODS FOR THE TREATMENT OF RENAL DISEASE - The present invention provides compounds and methods for the treatment and prophylaxis of renal disease and inflammation. In particular the invention provides methods for the treatment of kidney disease and failure through the administration of compounds which function as inhibitors of TLR2 function and expression. | 11-04-2010 |
| 20100247527 | COMPOSITION AND METHOD FOR TREATMENT OF AUTOIMMUNE DISEASE - The present invention provides compositions and methods for the treatment of autoimmune diseases, in particular rheumatoid arthritis. Compounds which function as antagonists of Toll-like Receptor 2 are shown to suppress the immune response which result in the onset and progression of autoimmune disease. In particular monoclonal antibodies which have a binding specificity to Toll-like receptor 2 are disclosed for use in methods for the treatment and/or prophylaxis of autoimmune disease. | 09-30-2010 |
